Exploiting the Differentiation Potential of Pediatric High-Grade Glioma to Discover Novel Therapeutic Opportunities |
Dana-Farber Cancer Institute / Mariella Filbin, MD/PhD |
'A' Award Grants |
2019 |
Massachusetts |
Synergistic Activity of Anti-GD2 Antibody and CD47-Blockade for Immunotherapy of Neuroblastoma and Osteosarcoma |
The Board of Trustees of the Leland Stanford Junior University / Robbie Majzner, MD |
'A' Award Grants |
2019 |
California |
Elucidating the Role of SETD2 in Pediatric High Grade Glioma Formation |
Children’s Hospital of Philadelphia / Thomas De Raedt, PhD |
'A' Award Grants |
2019 |
Pennsylvania |
Targeting a Novel Epigenetic Signature in Diffuse Intrinsic Pontine Gliomas |
New York University School of Medicine / Danny Reinberg, PhD |
Reach Grants |
2019 |
New York |
Preclinical Development of a First-in-Class PCNA Inhibitor for Treating Neuroblastoma |
City of Hope National Medical Center / Linda Malkas, PhD |
Reach Grants |
2019 |
California |
Generation of CMV-specific CD19 CAR T cells Using Cytokine Capture Followed by Lentiviral Transduction and Expansion |
Research Institute at Nationwide Children's Hospital / Margaret Lamb, MD |
Reach Grants |
2019 |
Ohio |
Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells |
Stanford University School of Medicine / Alice Bertaina, MD/PhD |
Reach Grants |
2019 |
California |
Multivalent Nanomedicine to Treat High-Risk Pediatric Solid Tumors |
Children’s Hospital of Philadelphia / Garrett Brodeur, MD |
Reach Grants |
2019 |
Pennsylvania |
Intervention Development and Evaluation to Reduce Disparities in Quality of Life for Latino Families Impacted by Cancer |
The Regents of the University of California, Irvine / Michelle Fortier, PhD |
Psychosocial Family Impact Grant |
2019 |
California |
Understanding factors contributing to retention in care among children with cancer in sub-Saharan Africa |
Baylor College of Medicine / Mark Zobeck, MD, PhD |
Psychosocial Launch Grant |
2019 |
Texas |